Therapeutic Catalyst funds collaborative projects that accelerate translating lab discoveries into new treatments for adult cancers. Focus areas include antibody-based therapeutics and small molecule approaches. Awards up to £350K over 12-24 months support direct research costs and outsourced activities. Open to academic researchers globally with independent labs. Applications reviewed thrice yearly with deadlines in February, May, and September.
Open to academic researchers worldwide based at universities or research institutes who have their own lab and/or perform independent research. Applicants must be engaged in cancer therapeutics research.
